Zeitschrift für Krebsdiagnose

Abstrakt

Carcinoembryonic Antigen, and it is Commonly Referred to by its Abbreviation ?CEA? in Medical and Scientific Contexts

Zhensin Min

Carcinoembryonic Antigen (CEA) is a glycoprotein that was originally discovered as a tumor marker in cancer research. It is a cell surface protein that is overexpressed in various cancers, particularly colorectal carcinoma, but can also be found at lower levels in healthy tissues. CEA has been extensively studied for its utility in cancer diagnosis, prognosis, and monitoring, as well as its potential as a therapeutic target. This abstract provides an overview of the structure, function, clinical significance, and current research related to CEA, highlighting its role in cancer management and its potential applications in the field of oncology.